Infinite Roots, a Hamburg, Germany-based biotech company using fermentation and fungi to create the next generation of sustainable alternative proteins, raised $58m in Series B funding.
The round was led by the Dr. Hans Riegel Holding GmbH (HRH), with the support from the EIC Fund, REWE Group, and Betagro Ventures.
The company intends to use the funds to move into a new era of commercial growth, expanding its production capacities and investing in launch activities worldwide.
Led by founder and CEO Mazen Rizk, Infinite Roots is a biotech company using fermentation and fungi to create the next generation of sustainable alternative proteins. The company grows and harvests mycelium as a versatile ingredient for planet-friendly meals.
Infinite Roots currently has a team of 60 people, from 25 different countries, speaking 15 different languages.
FinSMEs
26/01/2024